Tag Archives: Biologics by McKesson

Immunomedics Chooses Biologics as Sole Specialty Pharmacy Distributor

Trodelvy is the first anti-Trop-2 ADC recently approved by the FDA for the treatment of adult patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease

Limited Distribution Network for DOPTELET® Includes Biologics by McKesson

Dova recently entered into a merger agreement with Swedish Orphan Biovitrum AB (Sobi)

Biologics to Play Leading Role in McKesson’s Strategy

McKesson Corporation announced a multi-year strategic growth initiative in 2018, focused on creating innovative new solutions that improve patient care delivery and drive incremental profit growth. The initiative comprises multiple growth pillars, and includes a comprehensive review of the company’s operations and cost structure, designed to increase efficiency, accelerate execution and improve long-term performance. McKesson’s […]